Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice

Journal of Nutrition

Volumn 140, Issue 3, 2010, Pages 509-514

  Pachikian, Barbara D ^a   Neyrinck, Audrey M ^a   Deldicque, Louise ^b   De Backer, Fabienne C ^a   Catry, Emilie ^a   Dewulf, Evelyne M ^a   Sohet, Florence M ^a   Bindels, Laure B ^a   Everard, Amandine ^a   Francaux, Marc ^b   Guiot, Yves ^b   Cani, Patrice D ^a   Delzenne, Nathalie M ^a  

^a Louvain Drug Research Institute   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CCAAT ENHANCER BINDING PROTEIN; CD68 ANTIGEN; INTERLEUKIN 6; MESSENGER RNA; OCCLUDIN; PROGLUCAGON; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM; BLOOD SAMPLING; CECUM; CELL STRESS; COLITIS; ILEUM; INFLAMMATION; INTESTINE; INTESTINE FLORA; LIVER; MAGNESIUM DEFICIENCY; MALE; MOUSE; NONHUMAN; NUTRIENT UPTAKE; PROTEIN EXPRESSION;

ANIMALS; BIFIDOBACTERIUM; BODY WEIGHT; COLON; INFLAMMATION; MAGNESIUM; MALE; MICE; MICE, INBRED C57BL; NUTRITION DISORDERS;

MUS;

EID: 77249123907     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.117374     Document Type: Article

References (40)

1. Wolf FI, Cittadini A. Chemistry and biochemistry of magnesium. Mol Aspects Med. 2003;24:3-9.
2. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458:40-7.
3. Guerrero-Romero F, Rascon-Pacheco RA, Rodriguez-Moran M, de la Pena JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest. 2008;38: 389-96.
4. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002;39:209-13.
5. Lima ML, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R, Porto M, Cedro A, Vicente E. Serum and intracellular magnesium deficiency in patients with metabolic syndrome: evidences for its relation to insulin resistance. Diabetes Res Clin Pract. 2009;83:257-62.
6. Evangelopoulos AA, Vallianou NG, Panagiotakos DB, Georgiou A, Zacharias GA, Alevra AN, Zalokosta GJ, Vogiatzakis ED, Avgerinos PC. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res. 2008; 28:659-63.
7. Corica F, Corsonello A, Ientile R, Cucinotta D, Di BA, Perticone F, Dominguez LJ, Barbagallo M. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr. 2006;25:210-5.
8. Nozue T, Kobayashi A, Uemasu F, Takagi Y, Sako A, Endoh H. Magnesium status, serum HDL cholesterol, and apolipoprotein A-1 levels. J Pediatr Gastroenterol Nutr. 1995;20:316-8.
9. Guerrero-Romero F, Rodriguez-Moran M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications. 2000;14:272-6.
10. Sontia B, Touyz RM. Magnesium transport in hypertension. Pathophysiology. 2007;14:205-11.
11. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24:47-66.
12. Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys. 2007;458:33-9.
13. Hajjar I, Kotchen T. Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: the NHANES-III data. J Nutr. 2003;133:211-4.
14. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. 2007;458:48-56.
15. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28:1438-44.
16. Scanlan BJ, Tuft B, Elfrey JE, Smith A, Zhao A, Morimoto M, Chmielinska JJ, Tejero-Taldo MI, Mak I, et al. Intestinal inflammation stress-induced intestinal function. Mol Cell Biochem. 2007;306:59-69.
17. Malpuech-Brugere C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, Lebreton J, Mazur A, Rayssiguier Y. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta. 2000;1501:91-8.
18. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50: 2374-83.
19. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemiainduced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470-81.
20. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck AM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58: 1091-103.
21. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-72.
22. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431-3.
23. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr. 2004;92:521-6.
24. Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res. 2005;13:1000-7.
25. Dahlqvist A. Assay of intestinal disaccharidases. Anal Biochem. 1968;22:99-107.
26. Cameron HL, Perdue MH. Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther. 2005;314:214-20.
27. Cameron HL, Yang PC, Perdue MH. Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy. Am J Physiol Gastrointest Liver Physiol. 2003;284:G905-12.
28. Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000;47:112-9.
29. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem. 1992;110:169-73.
30. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15:1546-58.
31. Topouzian N, Joseph BJ, Bezkorovainy A. Effect of various metals and calcium metabolism inhibitors on the growth of Bifidobacterium bifidum var. pennsylvanicus. J Pediatr Gastroenterol Nutr. 1984;3: 137-42.
32. Molenkamp GC, Veerkamp JH. Effects of antibiotics on metabolism of peptidoglycan, protein, and lipids in Bifidobacterium bifidum subsp. pennsylvanicus. Antimicrob Agents Chemother. 1976;10:786-94.
33. Webb M. The influence of magnesium on cell division. IV. The specificity of magnesium. J Gen Microbiol. 1951;5:480-4.
34. Wang Z, Xiao G, Yao Y, Guo S, Lu K, Sheng Z. The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma. 2006;61:650-7.
35. Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D, et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci. 2004;49:579-89.
36. Wang ZT, Yao YM, Xiao GX, Sheng ZY. Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J Gastroenterol. 2004;10:1619-24.
37. Ruan X, Shi H, Xia G, Xiao Y, Dong J, Ming F, Wang S. Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition. 2007;23:754-61.
38. Chmielinska JJ, Tejero-Taldo MI, Mak IT, Weglicki WB. Intestinal and cardiac inflammatory response shows enhanced endotoxin receptor (CD14) expression in magnesium deficiency. Mol Cell Biochem. 2005;278:53-7.
39. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008;454:455-62.
40. Endo M, Oyadomari S, Suga M, Mori M, Gotoh T. The ER stress pathway involving CHOP is activated in the lungs of LPS-treated mice. J Biochem. 2005;138:501-7.